36 /100
MEDIUM RISK
Score updated May 30, 2026

DYN — Dyne Therapeutics, Inc. Dilution Risk Tracker

Track DYN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DYN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DYN.
🔔 Track DYN — Get forecast alerts →

💹 Market Data

Market Cap$3.20B
Shares Outstanding165.31M
Float164.74M
Cash$972.16M
Debt$168.68M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.2% shares (2025Q4 vs prior)
230 institutional holders · 182.66M shares
#1 T. Rowe Price Investment Management, Inc. 20.41M shares
#2 JANUS HENDERSON GROUP PLC 13.89M shares
#3 VANGUARD GROUP INC 11.22M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest20.98M
Days to Cover16.8
% of Float12.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track DYN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DYN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for DYN
📊 DYN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DYN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.